The slip
PARKINSON RECEIPTno. 6438
22 Oct 2026, 12:39 UTCdopamine neurons, braak
predictionMYCBP2 in dopamine neurons tracks Braak Lewy-body stage
registered2ebb6202efa4ad44
discovery+0.37 p=0.329 n=9
replication+0.46 p=0.216 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.37, p 0.329)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT8c4ba4b9e5c1427833af800f…
follows 6082c8cc7089…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 6438: MYCBP2 in dopamine neurons, braak
- power
- full sample +0.29 (p 0.235, n 18), 95% CI -0.20 to +0.67. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.35 (p 0.153, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.37 (p 0.135, n 18). could be the mix.
- skeptic
- leave-one-out range +0.20 to +0.44, sign flips 0; without severely affected donors +0.29 (p 0.235, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MYCBP2 in dopamine neurons.
case closed: nothing better to follow up.